Human immunodeficiency virus neutralizing antibodies and methods of use thereof

US12428472B2 · kind B2 · utility

Assignees

• The Rockefeller University · US
• CALIFORNIA INSTITUTE OF TECHNOLOGY · US

Inventors

• Johannes Scheid · New York, US
• Michel Nussenzweig · New York, US
• Pamela J. Bjorkman · Altadena, US
• Ron Diskin · Rehovot, IL

Key dates

• Filing date: Mar 6, 2024
• Grant date: Sep 30, 2025
• Expiry date: Mar 6, 2044

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.